EUVIMEDEUVIMED entdecken
Open Access

Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study

Ahmed I Soliman iD, Jean Wactawski-Wende, Amy E Millen, Kathleen M Hovey, Michael J LaMonte

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von Ahmed I Soliman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Environmental Health, University at Buffalo - SUNY, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Hemostasis, Proton Pump Inhibitors, Postmenopause. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, U.S. Army Reserve Medical Corps, National Institute for Dental and Craniofacial Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Examine the association between proton pump inhibitor (PPI) use and plasma levels of four biomarkers of haemostasis: fibrinogen, von Willebrand factor (vWF), high‐sensitivity CRP (hs‐CRP) and plasminogen activator inhibitor‐1 (PAI‐1) in postmenopausal women.

Methods

We conducted a cross‐sectional analysis on 200 women in the Buffalo Osteoporosis and Periodontitis study Year 17 visit. PPI use was assessed using medication inventories, and biomarkers were measured using frozen plasma samples. Linear regression was used to estimate mean differences for each biomarker according to PPI use (yes/no) and duration (≤ 1 year, > 1 year). Logistic regression was used to estimate the odds ratio (OR) and 95% confidence interval (95% CI) for having a high versus low level of each biomarker. Models were adjusted for major cardiovascular risk factors to account for potential confounding.

Results

PPI users had non‐statistically significant higher levels of vWF (mean difference = 52.9 mIU/mL, p = 0.38) and log hs‐CRP (mean difference = 0.1 mg/L, p = 0.5) compared to non‐users. PPI users for > 1 year had non‐statistically significant higher odds of having a high level of vWF (OR = 1.08, 95% CI: 0.51–2.31) and hs‐CRP (OR = 1.16, 95% CI: 0.58–2.33) compared to non‐users.

Conclusions

There was no significant association between PPI use and measured plasma haemostatic markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemostasisProton Pump InhibitorsPostmenopauseFemaleHumansBiomarkersCross-Sectional StudiesAgedMiddle Agedvon Willebrand FactorC-Reactive ProteinFibrinogenPlasminogen Activator Inhibitor 1

Stichwörter der Autor:innen

biomarkershaemostasispostmenopausalproton pump inhibitors

Substanzen

BiomarkersProton Pump Inhibitorsvon Willebrand FactorC-Reactive ProteinFibrinogenPlasminogen Activator Inhibitor 1

Autor:innen und Institutionen

  • Department of Epidemiology and Environmental Health, University at Buffalo - SUNY, Buffalo, New York, USA.

ORCID-Profile: Ahmed I Soliman

Förderung

  • NIDCR NIH HHS
  • U.S. Army Reserve Medical Corps
  • National Institute for Dental and Craniofacial Research
  • Saxon Graham Research Award
  • American Heart Association-American Stroke Association
  • Mark Diamond Research Fund
  • American Heart Association

Zitieren

APA

Soliman, A. I., Wactawski-Wende, J., Millen, A. E., Hovey, K. M., & LaMonte, M. J. (2026). Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70156

Vancouver

Soliman AI, Wactawski-Wende J, Millen AE, Hovey KM, LaMonte MJ. Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70156

BibTeX
@article{Soliman2026,
  author = {Soliman, Ahmed I and Wactawski-Wende, Jean and Millen, Amy E and Hovey, Kathleen M and LaMonte, Michael J},
  title = {Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70156}
}
Kostenlos starten →